The company leads a breakthrough revolution in biosensing technology. With over a decade of experience in sensors, transducers, and femtogram‑resolution QCM engineering, we developed two patented technologies that redefine what is possible in real‑time pathogen detection.

Our company transforms these scientific breakthroughs into commercial AI platforms capable of detecting airborne pathogens, biomarkers, and electrolytes with unprecedented sensitivity.

Our Mission

To bring femtogram‑level biosensing into real‑world applications — enabling early detection, epidemic prevention, and next‑generation public health intelligence.

Our Technology

Powered by our patented High Q‑Factor AT‑Cut QCM and Electrolyte/Biomarker Probe, our platform delivers:

• Real‑time airborne pathogen detection

• Femtogram mass resolution

• Antibody‑functionalized QCM surfaces

• AI‑driven pattern recognition

• Cloud‑based diagnostics via API

Our customers

A commercial Infectious Disease Detection API that integrates with:

• Hospitals

• Wearables

• Air‑quality systems

• Public‑health surveillance networks

• Health and life science
• Semiconductor manufacturing
• Pharmaceutical manufacturing
• Research Institutes
• Aerospace and defense industries

This is the future of biosensing — built in Canada, designed for the world.

A Visionary in Applied Biosensing

Dr. Mziray recognized early that QCM — already one of the world’s most sensitive mass sensors — could be transformed into a machine‑learning‑ready platform. By functionalizing QCM electrodes with specific antibodies, his company is creating a system capable of producing unique frequency signatures for each pathogen. These signatures are now used to train AI models that classify infectious diseases in real time. Under his leadership, the company:

• Building a commercial AI biosensing API

• Demonstrated real‑time airborne pathogen detection

• Developing a scalable cloud platform for global deployment

• Positions Canada as a leader in femtogram‑resolution diagnostics

Why Our QCM Is Different

• A five‑disk QCM array with center‑dot electrodes

• Ultra‑high Q‑factors for maximum frequency stability

• Mass sensitivity derived from Sauerbrey and Allan deviation models

• Operation in both air and ionic solutions

• Ability to detect pathogens, electrolytes, and biomarkers in seconds

Functionalization with Antibodies

The gold electrodes can be functionalized with:

• Anti‑troponin antibodies

• Viral antigens

• Bacterial antibodies

• Custom bioreceptors

This allows the QCM to selectively bind specific pathogens — producing a unique frequency signature for each target.

Machine Learning Integration

These signatures are processed by our AI engine using:

• Random Forest

• XGBoost

• LSTM neural networks

• Anomaly detection models

The result: real‑time infectious disease classification.

Commercial API

• Pathogen identification

• Biomarker concentration

• Risk scoring

• Early outbreak alerts